Core Viewpoint - Tianyi Medical (301097.SZ) has received an administrative penalty notice from the Ningbo Market Supervision Administration for allegedly failing to produce medical devices according to registered technical requirements, which may lead to significant financial penalties and operational adjustments [1][2]. Group 1: Administrative Penalty Details - The company was notified on December 19, 2025, regarding the administrative penalty for not adhering to the registered technical requirements for the production of blood purification devices [1]. - The investigation concluded that Tianyi Medical produced blood pathway products that did not comply with the registered specifications, violating the Medical Device Supervision and Administration Regulations [2]. - The proposed penalties include the confiscation of 7,170 sets of illegally produced medical devices and a fine totaling approximately 8.79 million yuan, along with the confiscation of illegal gains amounting to about 5.23 million yuan [2]. Group 2: Financial Impact - The total financial penalty for Tianyi Medical amounts to approximately 14.02 million yuan [3]. - The company went public on April 7, 2022, with an initial share price of 52.37 yuan, raising a total of approximately 77.18 million yuan in its IPO [3][4]. - The net proceeds from the IPO were about 69.46 million yuan, which was higher than the initially planned amount by approximately 18.45 million yuan [4].
天益医疗违规被罚没1402万 2022年上市即巅峰募7.7亿